Matches in Wikidata for { <http://www.wikidata.org/entity/Q94389947> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q94389947 description "scholarly article by J Marshall et al published 1 February 2018 in Journal of the Canadian Association of Gastroenterology" @default.
- Q94389947 description "wetenschappelijk artikel" @default.
- Q94389947 description "наукова стаття" @default.
- Q94389947 name "A123 INCREASING TIME ON TREATMENT IS PREDICTIVE OF IMPROVED LONG-TERM RETENTION FOR STABLE REMICADE (INFLIXIMAB) INFLAMMATORY BOWEL DISEASE PATIENTS IN CANADA" @default.
- Q94389947 name "A123 INCREASING TIME ON TREATMENT IS PREDICTIVE OF IMPROVED LONG-TERM RETENTION FOR STABLE REMICADE (INFLIXIMAB) INFLAMMATORY BOWEL DISEASE PATIENTS IN CANADA" @default.
- Q94389947 type Item @default.
- Q94389947 label "A123 INCREASING TIME ON TREATMENT IS PREDICTIVE OF IMPROVED LONG-TERM RETENTION FOR STABLE REMICADE (INFLIXIMAB) INFLAMMATORY BOWEL DISEASE PATIENTS IN CANADA" @default.
- Q94389947 label "A123 INCREASING TIME ON TREATMENT IS PREDICTIVE OF IMPROVED LONG-TERM RETENTION FOR STABLE REMICADE (INFLIXIMAB) INFLAMMATORY BOWEL DISEASE PATIENTS IN CANADA" @default.
- Q94389947 prefLabel "A123 INCREASING TIME ON TREATMENT IS PREDICTIVE OF IMPROVED LONG-TERM RETENTION FOR STABLE REMICADE (INFLIXIMAB) INFLAMMATORY BOWEL DISEASE PATIENTS IN CANADA" @default.
- Q94389947 prefLabel "A123 INCREASING TIME ON TREATMENT IS PREDICTIVE OF IMPROVED LONG-TERM RETENTION FOR STABLE REMICADE (INFLIXIMAB) INFLAMMATORY BOWEL DISEASE PATIENTS IN CANADA" @default.
- Q94389947 P1433 Q94389947-01267B88-28B0-4D5B-89E9-FF671B380FF0 @default.
- Q94389947 P1476 Q94389947-210409B7-F80C-4E04-A74A-008AAD6978CD @default.
- Q94389947 P2093 Q94389947-0BABA070-D232-4EC0-8FC0-FCF0E1045710 @default.
- Q94389947 P2093 Q94389947-4B01EFB6-81F0-4B5F-8B72-0357E195E0A1 @default.
- Q94389947 P2093 Q94389947-A53B844F-C6B0-4BFE-9297-25F99D9FAA26 @default.
- Q94389947 P304 Q94389947-08730F17-4845-44BF-BC5C-14E4E134C5A9 @default.
- Q94389947 P31 Q94389947-76D43356-03FF-40FD-8892-75D0ADBC1598 @default.
- Q94389947 P356 Q94389947-C6B137B2-A236-4FD9-BF52-0DBBA22B0BD4 @default.
- Q94389947 P433 Q94389947-A2BB42F4-E035-43FA-9C09-BF4E882B9DAA @default.
- Q94389947 P478 Q94389947-0A1FB968-1187-40E2-9954-56227D44A084 @default.
- Q94389947 P577 Q94389947-78FF9969-7FE2-4286-B0D0-A5B756FA0636 @default.
- Q94389947 P921 Q94389947-1EF69FF9-B1D8-4696-800B-9C43826DCBD7 @default.
- Q94389947 P921 Q94389947-3405974D-747F-462A-87A5-E8E31B64E7CD @default.
- Q94389947 P932 Q94389947-26A15B7D-A74D-4740-A5CD-78B2055B944A @default.
- Q94389947 P356 GWY008.124 @default.
- Q94389947 P1433 Q68835690 @default.
- Q94389947 P1476 "A123 INCREASING TIME ON TREATMENT IS PREDICTIVE OF IMPROVED LONG-TERM RETENTION FOR STABLE REMICADE (INFLIXIMAB) INFLAMMATORY BOWEL DISEASE PATIENTS IN CANADA" @default.
- Q94389947 P2093 "E Ewara" @default.
- Q94389947 P2093 "J Marshall" @default.
- Q94389947 P2093 "M Marrache" @default.
- Q94389947 P304 "214-215" @default.
- Q94389947 P31 Q13442814 @default.
- Q94389947 P356 "10.1093/JCAG/GWY008.124" @default.
- Q94389947 P433 "Suppl 1" @default.
- Q94389947 P478 "1" @default.
- Q94389947 P577 "2018-02-01T00:00:00Z" @default.
- Q94389947 P921 Q16 @default.
- Q94389947 P921 Q917447 @default.
- Q94389947 P932 "6507782" @default.